Heparin Calcium
drug drugOn this page
Also known as CalciparineEcasolvHeparin calcium saltHeparinum calcicumUniparin ca
Summary
Heparin Calcium (CHEMBL1201513) is an approved oligosaccharide; indicated across 2 conditions including habitual spontaneous abortion and immunoglobulin a vasculitis.
At a glance
- Status: Approved (max clinical phase 4)
- Modality: Oligosaccharide
- Indications: 2 conditions
Identifiers
Drug identity and classification
| Field | Value |
|---|---|
| ChEMBL ID | CHEMBL1201513 |
| Name | Heparin Calcium |
| Type | Oligosaccharide |
| Max phase | 4 |
Also known as: Calciparine, Ecasolv, Heparin calcium, Heparin calcium salt, Heparinum calcicum, Uniparin ca, HEPARIN CALCIUM
Targets
Targets
No target linkage available.
Bioactivity
No ChEMBL bioactivity rows at pChembl ≥ 5 (expected for biologics / antibodies).
Target pathways
No target-pathway data for this drug (no mapped target genes).
Indications & clinical
Indications
2 diseases in clinical trials (phase 1–3, investigational — not approved indications). Highest ChEMBL trial phase per disease; a non-cancer approved use is occasionally logged at phase 3 here.
| Disease (in trials) | Phase | MONDO | EFO |
|---|---|---|---|
| habitual spontaneous abortion | 2 | MONDO:0006774 | EFO:1000954 |
| immunoglobulin A vasculitis | 1 | MONDO:0019167 | EFO:1000965 |
Clinical trials
Total trials: 0.
Clinical evidence (CIViC)
No CIViC predictive evidence (expected for non-precision-medicine drugs).
Pharmacology
Pharmacogenomics
No PharmGKB pharmacogenomic data curated for this drug.
Related molecules
Related molecules
No competitor molecules sharing a primary target (ChEMBL phase ≥2 or PubChem drug-class).
Related Atlas pages
- In clinical trials for: habitual spontaneous abortion